Formulation and evaluation of fast disintegrating tablet of glimepiride
Glimepiride is the third generation sulphonylurea agent, used for the treatment of type II diabetes mellitus. Glimepiride is given once daily in doses from 1-4 mg. The objective of the present study was to formulate and evaluate the fast disintegrating tablets of Glimepiride. Method: The fast dissol...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
AMMANIF,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |